Recombinant Human GPC3 Protein-VLP, Active
Beta LifeScience
SKU/CAT #: BLK-00615P-100UG
Immobilized Human GPC3 VLP at 5ug/ml (100ul/Well) on the plate. Dose response curve for Anti-GPC3 Antibody, hFc Tag with the EC50 of 3.3ng/ml determined by ELISA.
Recombinant Human GPC3 Protein-VLP, Active
Beta LifeScience
SKU/CAT #: BLK-00615P-100UG
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Human GPC3 Protein-VLP is expressed from E.coli.It contains Gly510-Asn554. |
Accession | P51654 |
Target Symbol | GPC3 VLP |
Species | Human |
Expression System | E. coli |
Expression Range | Gly510-Asn554 |
Mol. Weight | The target protein has a predicted MW of 14 kDa. |
Form | Liquid |
Formulation | Supplied as 0.22um filtered solution in 20mM HEPES, 500mM NaCl, 10% Glycerol, 0.1% Tween20 (pH 7.7). |
Endotoxin | Less than 1EU per ug by the LAL method. |
Activity | Immobilized Human GPC3 VLP at 5ug/ml (100ul/Well) on the plate. Dose response curve for Anti-GPC3 Antibody, hFc Tag with the EC50 of 3.3ng/ml determined by ELISA. Contact us for detailed testing images. |
Storage | Valid for 12 months from date of receipt when stored at -80°C.; Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles. |
Shipping | Shipped with dry ice. |
Gene Background | Glypican-3 is a protein ,which is encoded by the GPC3 gene in humans.The protein core of GPC3 consists of two subunits, where the N-terminal subunit has a size of ~40 kDa and the C-terminal subunit is ~30 kDa.Glypican 3 is a potential therapeutic target for treating liver cancer and other cancers. Several therapeutic anti-GPC3 antibodies have been developed. |